Select Committee on Health Minutes of Evidence


Examination of Witnesses (Questions 440 - 459)

THURSDAY 13 JANUARY 2000

MR MARTIN BROUGHTON, MR PETER WILSON, MR GARETH DAVIS, MR DAVID DAVIES AND DR AXEL GIETZ

  440. Non-privileged documents?
  (Mr Gareth Davis) Yes, indeed.

  441. We can simply send for documents you know. What are you excluding when you use that term?
  (Mr Gareth Davis) Documents that have legal privilege.

  442. I think that you would need to consult the Clerk to the Committee before you excluded anything on those grounds because the Committee itself has privilege. Since you are using their names and that does carry an implication with it then I think you should be willing to substantiate that implication by letting us have the actual documents. If there are no documents then I think you should tell us that because that does call into question the extent and the weight and the thoroughness of the consultation that you had with them. Either way I think we would be very interested.
  (Mr Gareth Davis) I take your point, Mrs Wise, and I can only suggest to be helpful on this that I will put the Committee in touch with our people so that we can discuss how best we can assist you. As I say, I am not totally familiar with the archive myself or the practical and legal issues associated with it. I will also take advice before providing you with our full response. I think that is as helpful as I possibly can be.

Mr Burns

  443. Can I move on slightly to when the tobacco companies knew about the risks associated with smoking. When did your companies reach their current public stance on the risks of smoking?
  (Mr Wilson) That is a hard one to answer. We have acknowledged the risks going back to the 1950s when the first Doll and Hill Report was published. We immediately worked both within the industry and with Government to address the very significant and important issues that were raised there.

  444. Can I come back to that in a minute when I have had answers from your colleagues.
  (Mr David Davies) We have acknowledged the statistical association for decades. I think it is fair to say that our thinking has evolved on this issue over the course of the years. Today our position is quite clear in acknowledging the consensus in the medical and scientific community that smoking causes serious diseases. If you are a smoker the only safe thing to do is to stop smoking. If you are not a smoker then the only safe thing to do is not to begin to smoke.
  (Mr Broughton) As Mr Wilson said, since the mid-1950s or early 1950s the working hypothesis of research has been that there is a link between smoking and health and, therefore, let us assume that is the case and do some research. The changing position of the company is like anything else, as time goes by you get more information. A lot of it comes down to the different roles. The company has never done epidemiological studies, that is not the role of the company, I think that is the role of academics, scientists, public policy persons. The role of the company is to say "Let us take this as a working hypothesis and see what can be done about it? What are the biological mechanisms that are likely to be causing these statistics to come out? What product modifications can be made?" From a research position, since the 1950s we have taken that as a working assumption and the research within the company has been directed towards "Okay, now what? What can be done about it?"

Chairman

  445. Could you be specific about when in the 1950s? There is a reason behind my question. The first ever statement that was made by a Health Minister in this place was in 1954. When would you accept that there was a general consensus around this working hypothesis that you have referred to among all of these tobacco companies?
  (Mr Broughton) I thought it was 1952 actually.

  446. Possibly.
  (Mr Broughton) The early 1950s. I think that was the first time when there was serious epidemiological evidence. From time immemorial, from James I to the First World War comments about "coffin nails", I do not think the industry has ever worked on the assumption that these are safe. I think the real research into the hypothesis that these are unsafe and what are we going to do about this was in the very early 1950s, 1952 or 1954. I cannot be certain which year but it was around about then.
  (Mr Gareth Davis) I would echo the formation of it was in the early 1950s and through the 1950s. Indeed, my belief is that the Harrogate Laboratory established in 1962 was set up to work on the basis of that working hypothesis. To answer you specifically, the positions that we have arrived at are based on our internal experts reviewing the literature, the studies, and taking expert advice from scientists outside of the company. I would say that it is over the last ten years or so that those positions have become more clear.
  (Dr Gietz) The research work and the development work in this context is more important. It certainly began around the time that my colleagues have mentioned.

Mr Burns

  447. The research work began rather than you actually discovered?
  (Dr Gietz) Within our company. What is important to explain is the role that the scientists in the R&D department of, say, our company have. They do not do the medical research, they monitor the medical research, they monitor what the scientific community comes up with, as it were, and then review it and try to translate it into responsible development work. This is certainly what they have done since this point in time that we can jointly agree on.

  448. So by and large it would be fair to say that from the early/mid-1950s your companies knew that there were risks and dangers to health related to smoking?
  (Dr Gietz) If I may, the important point is that our scientists at no point knew anything that nobody else knew. It was not that they had privileged knowledge, it was the other way around really. They monitor what others have developed.

  449. Given that from the early/mid-1950s it was generally known in your companies that there were risks and health related problems with regard to the product that you produce, what did your companies do, what action did they take having reached that decision bearing in mind, and you may want to give evidence to refute this, it would seem to the outside observer that ever since that time until fairly recently kicking and screaming your companies have objected to things even like the size of the health warning on a packet of cigarettes, the question of advertising of cigarettes?
  (Mr Wilson) Let me volunteer. In the 1950s when the reports starting with Doll and Hill first emerged, that caused considerable concern, yes. I was not around at that time, please understand that, I am doing my best to try to recreate what went on. This resulted in a significant amount of research by the industry and individual companies and involving Government. That research started on a simple premise as we set out in our submission—and it is there so if I am wasting your time, please tell me—to try to understand what it was in a tobacco product that was causing the potential damage with a view to identifying it and then eliminating it. That proved immensely complex. It started off on the basis that there were about 20 different elements in tobacco smoke and the more this was analysed the more complex it got and today I believe there are probably somewhere around 3,500 to 4,000 elements in tobacco smoke. It became clear after a considerable while that this was not going to be a fertile way forward. The work then changed to start seeing how cigarettes could be modified and that led to the development of the low tar programme tobacco substitutes and other things which I am happy to talk about should you wish to do so. Certainly in 1971 we voluntarily put health warnings on our packs. You talked about not doing this or not wishing to do this but we have done it.

  450. No, I did not say that at all. What I said was arguments about the size of the warnings on packets of cigarettes, not that you refused to do it although now you have no choice in the matter. Certainly there were arguments as recently as the late 1980s when you as an industry objected to larger sized health warnings on packets of cigarettes.
  (Mr Wilson) I think that particular point you are making relates to an interpretation of the European Directive which was there to harmonise the size of health warnings across Europe. We had one interpretation of it and the Government had another interpretation.

  451. But you fought the Government's interpretation?
  (Mr Wilson) Yes, we did.

  452. Which was to have larger ones.
  (Mr Wilson) Because we thought it was a wrong interpretation of the Directive.

  453. Even if that were the case, and I am not conceding that was the case, if my memory is right what the Government was doing in their interpretation of that Directive was to have larger health warnings on packets of cigarettes and you were fighting that on the basis that you felt the Government had wrongly interpreted an EU Directive. That does seem like splitting hairs and relatively unimportant if one is concerned about making something as prominent as possible for the potential customer of the risks of the product they are going to buy or they had bought.
  (Mr Wilson) It is all a question of degree. We have agreed since 1971, as I say, to health warnings on our packs. Going back before that there was ample evidence, and we have summarised it in our submission to you, of the high level of awareness of the risks of smoking in the population at large. To me the essential thing is to ensure that every smoker is aware of the risks. Whether the health warning is four per cent or five per cent, the important thing is that the message is there. We are more than happy to co-operate with the Government but we need to make certain that we are working to the objective of getting that message across. It is important to us how much of our pack is devoted to the competitive issues, of having a pack of cigarettes which our smokers can choose in preference to our competitors' brands, and at the same time creating the right balance on that pack in getting the health message across. Yes, there were differences of view between us and Government as to what that right balance was.

  454. Fair enough.
  (Mr Wilson) The message has to be there.

  455. If the message is so important to warn people of the dangers related to smoking, why is it that in the past, in the relatively recent past, certain tobacco companies have targeted the next generation of smokers, ie children? Why have they used cartoon characters for getting across their message which particularly attract the young people? Why do they spend so much time seeking to open up the highly lucrative Far Eastern market?
  (Mr Wilson) We do not target children in any way.

  456. I said until relatively recently tobacco companies have through the use of cartoon characters for advertising, etcetera, etcetera. It may not be happening at this moment but it certainly has happened in the recent past.
  (Mr Broughton) We do not target children for advertising.

  457. Not now but you will accept it has been done in the past. Joe Camel?
  (Mr Broughton) You will have to address that question to Dr Gietz.

  458. The Flintstones?
  (Mr Broughton) I do not recall—and I cannot say this with certainty—any case of British American Tobacco using cartoon characters.

  459. But the tobacco industry has in the western world.
  (Mr Broughton) I think in essence the point you are getting at is why do youth start smoking and in all of the studies that have been done I do not think you will find that it is because they like an advert. I think you will find there is ample evidence to say it is peer pressure, it is parental behaviour, it is various societal issues and I do not think it is actually for great debate from the research. When you ask, and it is not us who ask, children why they start they do not refer to advertising as a reason.

  Mr Burns: No but they might be influenced by an image conveyed by an advertisement, however subtley it is done. For example, and I go back to American advertising techniques, cartoon characters can be helpful. The classic Marlboro advert of the macho cowboy on the horse in the far West of the States, that all creates (to use common parlance) a "cool" image that certainly in the past may well, almost certainly did, attract young people to start smoking because they thought it was cool and it dovetailed in or linked in with other issues you have mentioned like peer pressure, etcetera, but advertising did have a role to play which the tobacco companies fully exploited at the time.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries

© Parliamentary copyright 2000
Prepared 28 February 2000